Recent studies have shown that mutations in human KLF11 gene or KLF11 binding element in the human insulin promoter, which impairs KLF11 binding to promoter and activation of insulin gene promoter, results in diabetes leading to decreased human insulin biosynthesis [15], [19]. This evidence concerns the gene KLF11 and diabetes mellitus.